NCT07125001

Brief Summary

Mangos contain a number of nutrients that may improve gut and metabolic health. The purpose of this research is to see how eating mangos every day for 4 weeks instead of snacks high in calories and low in nutrients such as cookies, crackers, chips, and candy can impact adolescent health.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
23mo left

Started Oct 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Oct 2025Mar 2028

First Submitted

Initial submission to the registry

July 7, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 15, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2028

Last Updated

February 3, 2026

Status Verified

January 1, 2026

Enrollment Period

2.5 years

First QC Date

July 7, 2025

Last Update Submit

January 29, 2026

Conditions

Keywords

mangocardiometabolicadolescentsmicrobiome

Outcome Measures

Primary Outcomes (1)

  • Microvascular Function

    Microvascular function as measured by peripheral arterial tonometry (ENDO PAT 2000)

    4 weeks

Secondary Outcomes (9)

  • Cytokines

    4 weeks

  • short chain fatty acids

    4 weeks

  • Bile acids

    4 weeks

  • zonulin

    4 weeks

  • soluble lipopolysaccharide binding protein

    4 weeks

  • +4 more secondary outcomes

Study Arms (2)

Mango arm

EXPERIMENTAL

Ataulfo Mango intake

Other: Ataulfo mango

No mango intake

NO INTERVENTION

4 weeks of no mango intake

Interventions

4 weeks of Ataulfo mango intake

Mango arm

Eligibility Criteria

Age12 Years - 19 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • \- Male or Female 12-19 years old
  • BMI ≥ 85th percentile (https://www.bcm.edu/bodycomplab/BMIapp/BMI-calculator-kids.html)
  • Self-reported Hispanic/Latino
  • Subject is willing and able to comply with the study protocols
  • Subject is willing to consume the test products
  • Female-specific criteria: if menstruating, eumenorrheic (regular monthly menstrual cycles of 25-30-days in length)
  • Access to a smartphone or tablet at least 1x / day and willing to take pictures associated with the products to be consumed in the study

You may not qualify if:

  • \- Reported food allergies.
  • Currently taking prescription drugs, with the exception of asthma inhalers, which are allowed
  • BMI \<85th percentile (https://www.bcm.edu/bodycomplab/BMIapp/BMI-calculator-kids.html)
  • Current participation in a moderate or high-intensity daily exercise routine
  • Self-reported disease, serious illness, or who are currently under acute medical care.
  • Currently taking prescription drugs.
  • Any supplement use, including multi-vitamin/ mineral, herbal, plant or botanical, fish oil, and oil supplements, and not willing to discontinue before starting the study.
  • Vegetarian or vegan diet
  • Self-reported malabsorption or gastrointestinal issues
  • Fruit and vegetable intake exceeding daily recommendations of 5 servings
  • Smoking (vaping, conventional nicotine-containing products or marijuana)
  • Current enrollee in a clinical research study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Academic Surge; Ragle Human Nutrition Research Center

Davis, California, 95616, United States

RECRUITING

MeSH Terms

Conditions

Inflammation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Roberta R Holt, PhD

    University of California, Davis

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Roberta R Holt, PhD

CONTACT

Genesis G Guerra Gaitan, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2025

First Posted

August 15, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

March 31, 2028

Study Completion (Estimated)

March 31, 2028

Last Updated

February 3, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations